Neurocea Neurocea is a biopharmaceutical company engaged in developing oral therapy for CNS (central nervous system) diseases. | Rigel Pharmaceuticals Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases. | ![]() Neopharm Boston Neopharm Boston (formerly Averica Discovery Services) is an analytical development contract research organization. | ![]() Terns Pharmaceuticals Terns Pharmaceuticals is a biopharmaceutical company developing small-molecule single-agent and combination therapy for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. | |
Founding Date | Founding Date 2012 | Founding Date 1996 | Founding Date 2007 | Founding Date 2017 |
Type | Type Private | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations US HQ | Locations South San Francisco, US HQ | Locations Marlborough, US HQ | Locations Foster City, US HQ |
Employees | Employees 7 | Employees 1633% increase | Employees 717% increase | Employees 59 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 256 m | Valuation ($) N/A | Valuation ($) 580.9 m |
Financial | ||||
Net income | Net income N/A | Net income $367m (FY, 2025) | Net income N/A | Net income ($96.2m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 130m | Total funding raised N/A | Total funding raised $ 30m |
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
View company
Neopharm Boston (formerly Averica Discovery Services) is an analytical development contract research organization.
View company
Terns Pharmaceuticals is a biopharmaceutical company developing small-molecule single-agent and combination therapy for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases.
View company